AI Analysis AI Analysis of CLNN
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Clene Inc. stock price up 1.06% on Monday
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Nov 13, 2025 Gain 20.25%

The Clene Inc. stock price gained 1.06% on the last trading day (Monday, 17th Nov 2025), rising from $8.52 to $8.61. During the last trading day the stock fluctuated 8.50% from a day low at $8.00 to a day high of $8.68. The price has fallen in 5 of the last 10 days and is down by -28.13% for this period. Volume fell on the last day by -124 thousand shares and in total, 93 thousand shares were bought and sold for approximately $804.33 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 67.82% during the next 3 months and, with a 90% probability hold a price between $12.30 and $22.54 at the end of this 3-month period.

CLNN Signals & Forecast

There are few to no technical positive signals at the moment. The Clene Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $9.04 and $9.08. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, October 31, 2025, and so far it has fallen -31.12%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Clene Inc. stock

Clene Inc. finds support from accumulated volume at $8.52 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.680 between high and low, or 8.50%. For the last week the stock has had daily average volatility of 18.71%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CLNN) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Clene Inc. to open at $8.43, and during the day (based on 14 day Average True Range), to move between $7.97 and $9.25, which gives a possible trading interval of +/-$1.27 (+/-15.97%) up or down from last closing price. If Clene Inc. takes out the full calculated possible swing range there will be an estimated 15.97% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.52 (1.05%) than the resistance at $9.07 (5.34%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Clene Inc. stock A Buy?

The Clene Inc. stock holds several negative signals and despite the positive trend, we believe Clene Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.176 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $8.43 ( 2.09%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

CLNN Performance

Trading levels for CLNN

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 9.11 5.81%
R2 8.85 2.79%
R1 8.69 0.93%
Price 8.61
S1 8.17 -5.11%
S2 8.01 -6.97%
S3 7.75 -9.99%

Accumulated Volume Support & Resistance Levels

Level Price
R3 10.51 22.07%
R2 10.36 20.33%
R1 9.07 5.34%
Price 8.61
S1 8.52 -1.05%
S2 8.01 -6.97%
S3 6.63 -23.00%

FAQ

What is the symbol for Clene Inc. Stock and on which exchange is it traded?
The symbol for Clene Inc. is CLNN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Clene Inc. Stock?
The Clene Inc. stock holds several negative signals and despite the positive trend, we believe Clene Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Clene Inc. Stock?
Clene Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Clene Inc. Stock.

What's the current price of Clene Inc. Stock?
As of the end of day on the Nov 17, 2025, the price of an Clene Inc. (CLNN) share was $8.61.

What is the 52-week high and low for Clene Inc. Stock?
The 52-week high for Clene Inc. Stock is $13.50 and the 52-week low is $2.28.

What is the market capitalization of Clene Inc. Stock?
As of the Nov 17, 2025, the market capitalization of Clene Inc. is 80.11M.

When is the next earnings date for Clene Inc.?
The upcoming earnings date for Clene Inc. is Mar 23, 2026.
Click to get the best stock tips daily for free!
ABOUT CLENE INC.
Clene
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; com...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE